基本信息
浏览量:423
职业迁徙
个人简介
Brian Druker, M.D., revolutionized the treatment of cancer through research that resulted in the first drug to target the molecular defect of a cancer while leaving healthy cells unharmed. Marketed under the name Gleevec®, his discovery turned a once-fatal cancer, chronic myeloid leukemia, into a manageable condition.
Treatment with Gleevec received FDA approval in record time, was featured on the cover of Time magazine, and established Druker as a pioneer in the field of precision medicine. Most important, his discovery became a new proof of principal for targeted therapies, spurring the development of more than 50 similar precision therapies for other cancers.
Druker now is applying key principles of precision medicine to early detection. Earlier detection of lethal cancers represents the greatest opportunity to increase cancer survival rates. Thanks to $1 billion in philanthropic funding, Druker is developing a large-scale early detection program that builds upon the scientific strengths of OHSU’s Knight Cancer Institute.
Druker has been recognized with numerous awards, including the Sjöberg Prize from the Royal Swedish Academy of Sciences, the Warren Alpert Prize from Harvard Medical School, the Lasker-DeBakey Award for Clinical Medical Research, the Japan Prize in Healthcare and Medical Technology, the Tang Prize in Biopharmaceutical Science, and the Prince Mahidol Award for outstanding achievements in medicine and public health worldwide. He has been elected to the National Academy of Medicine, the National Academy of Sciences and the American Academy of Arts and Sciences.
Treatment with Gleevec received FDA approval in record time, was featured on the cover of Time magazine, and established Druker as a pioneer in the field of precision medicine. Most important, his discovery became a new proof of principal for targeted therapies, spurring the development of more than 50 similar precision therapies for other cancers.
Druker now is applying key principles of precision medicine to early detection. Earlier detection of lethal cancers represents the greatest opportunity to increase cancer survival rates. Thanks to $1 billion in philanthropic funding, Druker is developing a large-scale early detection program that builds upon the scientific strengths of OHSU’s Knight Cancer Institute.
Druker has been recognized with numerous awards, including the Sjöberg Prize from the Royal Swedish Academy of Sciences, the Warren Alpert Prize from Harvard Medical School, the Lasker-DeBakey Award for Clinical Medical Research, the Japan Prize in Healthcare and Medical Technology, the Tang Prize in Biopharmaceutical Science, and the Prince Mahidol Award for outstanding achievements in medicine and public health worldwide. He has been elected to the National Academy of Medicine, the National Academy of Sciences and the American Academy of Arts and Sciences.
研究兴趣
论文共 1027 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
James C. Pino,Camilo Posso,Sunil K. Joshi,Michael Nestor,Jamie Moon,Joshua R. Hansen,Chelsea Hutchinson-Bunch,Marina A. Gritsenko,Karl K. Weitz,Kevin Watanabe-Smith,Nicola Long,Jason E. McDermott,Brian J. Druker,Tao Liu,Jeffrey W. Tyner,Anupriya Agarwal,Elie Traer,Paul D. Piehowski,Cristina E. Tognon,Karin D. Rodland
Cell Reports Medicineno. 1 (2024): 101359-101359
Ellin Berman,Neil P. Shah, Michael Deninger,Jessica K. Altman,Maria Amaya,Kebede Begna,Ravi Bhatia,Onyee Chan,Robert Collins,Peter Curtin,Daniel J. DeAngelo,Michael Drazer,Lori Maness,Leland Metheny,Sanjay Mohan,Joseph Moore,Vivian Oehler,Keith Pratz,Iskra Pusic,Michal Rose,William Shomali,B. Douglas Smith,Michael Styler,Kendra Sweet,Moshe Talpaz, Tiffany Tanaka,Srinivas Tantravahi,Steven Tsai,Jennifer Vaughn,Jeanna Welborn,David Yang,Michael Mauro,Jorge Cortes,Jerald Radich,Brian Druker
Christopher A. Eide, Diana Brewer, Tao Xie,Anna Reister Schultz,Samantha L. Savage,Serena Muratcioglu, Noah Merz, Richard D. Press, Thomas O’Hare,Thomas Jacob,Tania Q. Vu,Cristina E. Tognon, Tara A. Macey,John Kuriyan,Charalampos G. Kalodimos,Brian J. Druker
Cancer cellno. 9 (2024): 1486-1488
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2024): 455-479
Ellin Berman,Neil P. Shah,Michael W. Deininger,Jessica K. Altman,M.F. Amaya,Kebede H. Begna, Ravi Bhatia,Onyee Chan,Robert H. Collins, Peter Curtin,Daniel J. DeAngelo,Michael W. Drazer, Lori J. Maness,Leland Metheny,Sanjay Mohan, Joseph Earle Moore,Vivian G. Oehler,Keith W. Pratz,Iskra Pusic, Michal G. Rose,William Shomali,B. Douglas Smith,Michael Styler,Kendra Sweet,Moshe Talpaz,Tiffany Tanaka,Srinivas K. Tantravahi, Shau‐Wei Tsai,Jennifer Vaughn, Jeanna Welborn, David T. Yang,Michael J. Mauro,Jorge Cortes,Jerald P. Radich,Brian J. Druker
Journal of clinical oncologyno. 9 (2024): 984-986
Sheng F. Cai,Ying Huang, Jennie R. Lance, Hsiaoyin Charlene Mao,Andrew J. Dunbar,Samantha N. McNulty,Todd Druley,Yan Li,Maria R. Baer,Wendy Stock,Tibor Kovacsovics,William G. Blum,Gary J. Schiller,Rebecca L. Olin,James M. Foran,Mark Litzow,Tara Lin,Prapti Patel, Matthew C. Foster,Michael Boyiadzis,Robert H. Collins,Jordan Chervin,Abigail Shoben,Jo-Anne Vergilio,Nyla A. Heerema,Leonard Rosenberg,Timothy L. Chen,Ashley O. Yocum,Franchesca Druggan,Sonja Marcus,Mona Stefanos,Brian J. Druker,Alice S. Mims,Uma Borate,Amy Burd,John C. Byrd,Ross L. Levine,Eytan M. Stein
Takaomi Sanda,Jeffrey W. Tyner,Alejandro Gutierrez,Vu N. Ngo,Jason Glover,Bill H. Chang,Arla Yost,Wenxue Ma,Angela G. Fleischman,Wenjun Zhou,Yandan Yang,Maria Kleppe,Yebin Ahn,Jessica Tatarek,Michelle A. Kelliher,Donna S. Neuberg,Ross L. Levine,Richard Moriggl,Mathias Müller, Nathanael S. Gray,Catriona H.M. Jamieson,Andrew P. Weng,Louis M. Staudt,Brian J. Druker,A. Thomas Look
crossref(2023)
Takaomi Sanda,Jeffrey W. Tyner,Alejandro Gutierrez,Vu N. Ngo,Jason Glover,Bill H. Chang,Arla Yost,Wenxue Ma,Angela G. Fleischman,Wenjun Zhou,Yandan Yang,Maria Kleppe,Yebin Ahn,Jessica Tatarek,Michelle A. Kelliher,Donna S. Neuberg,Ross L. Levine,Richard Moriggl,Mathias Müller, Nathanael S. Gray,Catriona H.M. Jamieson,Andrew P. Weng,Louis M. Staudt,Brian J. Druker,A. Thomas Look
crossref(2023)
Fieke W. Hoff,Ying Huang,Rina Li Welkie,Ronan T. Swords,Elie Traer,Eytan M. Stein,Tara L. Lin,Prapti A. Patel,Robert H. Collins,Maria R. Baer,Vu H. Duong,William Blum,Martha Arellano,Wendy Stock,Olatoyosi Odenike,Robert L. Redner,Tibor J. Kovacsovics,Michael W. Deininger,Joshua F. Zeidner,Rebecca Olin,Catherine C. Smith,James M. Foran,Gary J. Schiller,Emily K. Curran,Kristin L. Koenig,Nyla A. Heerema,Timothy Chen,Molly Martycz,Mona Stefanos,Sonja Gullen Marcus,Leonard Rosenberg,Brian J. Druker,Ross L. Levine,Amy Burd,Ashley Owen Yocum,Uma M. Borate,Alice Mims,John C. Byrd,Yazan F. Madanat
Bloodno. Supplement 1 (2023): 4296-4296
加载更多
作者统计
#Papers: 1026
#Citation: 107625
H-Index: 130
G-Index: 319
Sociability: 9
Diversity: 0
Activity: 5
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn